4 studies found for:    4938153 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
Condition: Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF
Intervention: Biological: CD133+ cells transplant
2 Terminated Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Esophageal Neoplasms;   Esophageal Diseases
Interventions: Drug: Erlotinib;   Drug: Avastin
3 Recruiting Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Condition: Glioblastoma
Intervention:
4 Completed A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
Conditions: Non-Small Cell Lung Cancer;   Adenocarcinoma
Interventions: Drug: SS1 (dsFv) PE38;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab

Indicates status has not been verified in more than two years